Global Human Prothrombin Complex Competitive Landscape Professional Research Report 2025
Research Summary
Human prothrombin complex, also known as prothrombin complex concentrate (PCC), is a medication derived from blood plasma that contains concentrated forms of blood clotting factors. It is used in medical settings to manage bleeding disorders, particularly in situations where there is a deficiency or dysfunction of certain clotting factors. Prothrombin complex contains factors II (prothrombin), VII, IX, and X, along with proteins C and S. Administered intravenously, prothrombin complex can rapidly increase the levels of these clotting factors in the bloodstream, facilitating blood clotting and helping to control bleeding. This treatment is commonly employed in emergency situations, such as during surgeries, trauma, or for individuals with hereditary or acquired clotting factor deficiencies. The use of prothrombin complex is carefully monitored and tailored to the specific needs of the patient based on laboratory tests and clinical indications.
According to DIResearch's in-depth investigation and research, the global Human Prothrombin Complex market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Human Prothrombin Complex include Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Human Prothrombin Complex. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Prothrombin Complex market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Prothrombin Complex market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Prothrombin Complex industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Prothrombin Complex Include:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Human Prothrombin Complex Product Segment Include:
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Human Prothrombin Complex Product Application Include:
Hemophilia B
Vitamin K Deficiency
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Human Prothrombin Complex Industry PESTEL Analysis
Chapter 3: Global Human Prothrombin Complex Industry Porter’s Five Forces Analysis
Chapter 4: Global Human Prothrombin Complex Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Human Prothrombin Complex Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Human Prothrombin Complex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Human Prothrombin Complex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Human Prothrombin Complex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Human Prothrombin Complex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Human Prothrombin Complex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Human Prothrombin Complex Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Human Prothrombin Complex Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Human Prothrombin Complex Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Human Prothrombin Complex Product by Type
- 1.2.1 500 IU/Vial
- 1.2.2 600 IU/Vial
- 1.2.3 1000 IU/Vial
- 1.2.4 Others
- 1.3 Human Prothrombin Complex Product by Application
- 1.3.1 Hemophilia B
- 1.3.2 Vitamin K Deficiency
- 1.3.3 Others
- 1.4 Global Human Prothrombin Complex Market Revenue and Sales Analysis
- 1.4.1 Global Human Prothrombin Complex Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Human Prothrombin Complex Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Human Prothrombin Complex Market Sales Price Trend Analysis (2020-2032)
- 1.5 Human Prothrombin Complex Industry Trends and Innovation
- 1.5.1 Human Prothrombin Complex Industry Trends and Innovation
- 1.5.2 Human Prothrombin Complex Market Drivers and Challenges
- 2 Human Prothrombin Complex Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Human Prothrombin Complex Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Human Prothrombin Complex Market Analysis by Regions
- 4.1 Human Prothrombin Complex Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Human Prothrombin Complex Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Human Prothrombin Complex Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Human Prothrombin Complex Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Human Prothrombin Complex Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Human Prothrombin Complex Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Human Prothrombin Complex Sales Forecast by Region (2026-2032)
- 4.4 Global Human Prothrombin Complex Sales Price Trend Analysis (2020-2032)
- 5 Global Human Prothrombin Complex Market Size by Type and Application
- 5.1 Global Human Prothrombin Complex Market Size by Type
- 5.1.1 Global Human Prothrombin Complex Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Human Prothrombin Complex Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Human Prothrombin Complex Market Size by Application
- 5.2.1 Global Human Prothrombin Complex Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Human Prothrombin Complex Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Human Prothrombin Complex Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Human Prothrombin Complex Market Size by Type
- 6.3.1 North America Human Prothrombin Complex Sales by Type (2020-2032)
- 6.3.2 North America Human Prothrombin Complex Revenue by Type (2020-2032)
- 6.4 North America Human Prothrombin Complex Market Size by Application
- 6.4.1 North America Human Prothrombin Complex Sales by Application (2020-2032)
- 6.4.2 North America Human Prothrombin Complex Revenue by Application (2020-2032)
- 6.5 North America Human Prothrombin Complex Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Human Prothrombin Complex Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Human Prothrombin Complex Market Size by Type
- 7.3.1 Europe Human Prothrombin Complex Sales by Type (2020-2032)
- 7.3.2 Europe Human Prothrombin Complex Revenue by Type (2020-2032)
- 7.4 Europe Human Prothrombin Complex Market Size by Application
- 7.4.1 Europe Human Prothrombin Complex Sales by Application (2020-2032)
- 7.4.2 Europe Human Prothrombin Complex Revenue by Application (2020-2032)
- 7.5 Europe Human Prothrombin Complex Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Human Prothrombin Complex Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Human Prothrombin Complex Market Size by Type
- 8.3.1 China Human Prothrombin Complex Sales by Type (2020-2032)
- 8.3.2 China Human Prothrombin Complex Revenue by Type (2020-2032)
- 8.4 China Human Prothrombin Complex Market Size by Application
- 8.4.1 China Human Prothrombin Complex Sales by Application (2020-2032)
- 8.4.2 China Human Prothrombin Complex Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Human Prothrombin Complex Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Human Prothrombin Complex Market Size by Type
- 9.3.1 APAC (excl. China) Human Prothrombin Complex Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Human Prothrombin Complex Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Human Prothrombin Complex Market Size by Application
- 9.4.1 APAC (excl. China) Human Prothrombin Complex Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Human Prothrombin Complex Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Human Prothrombin Complex Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Human Prothrombin Complex Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Human Prothrombin Complex Market Size by Type
- 10.3.1 Latin America Human Prothrombin Complex Sales by Type (2020-2032)
- 10.3.2 Latin America Human Prothrombin Complex Revenue by Type (2020-2032)
- 10.4 Latin America Human Prothrombin Complex Market Size by Application
- 10.4.1 Latin America Human Prothrombin Complex Sales by Application (2020-2032)
- 10.4.2 Latin America Human Prothrombin Complex Revenue by Application (2020-2032)
- 10.5 Latin America Human Prothrombin Complex Market Size by Country
- 10.6 Latin America Human Prothrombin Complex Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Human Prothrombin Complex Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Human Prothrombin Complex Market Size by Type
- 11.3.1 Middle East & Africa Human Prothrombin Complex Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Human Prothrombin Complex Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Human Prothrombin Complex Market Size by Application
- 11.4.1 Middle East & Africa Human Prothrombin Complex Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Human Prothrombin Complex Revenue by Application (2020-2032)
- 11.5 Middle East Human Prothrombin Complex Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Human Prothrombin Complex Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Human Prothrombin Complex Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Human Prothrombin Complex Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Human Prothrombin Complex Average Sales Price by Manufacturers (2021-2025)
- 12.2 Human Prothrombin Complex Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Human Prothrombin Complex Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Takeda
- 13.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Takeda Human Prothrombin Complex Product Portfolio
- 13.1.3 Takeda Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 CSL
- 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CSL Human Prothrombin Complex Product Portfolio
- 13.2.3 CSL Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Grifols
- 13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Grifols Human Prothrombin Complex Product Portfolio
- 13.3.3 Grifols Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Octapharma
- 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Octapharma Human Prothrombin Complex Product Portfolio
- 13.4.3 Octapharma Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Hualan Biological
- 13.5.1 Hualan Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Hualan Biological Human Prothrombin Complex Product Portfolio
- 13.5.3 Hualan Biological Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Meheco Xinxing Pharma
- 13.6.1 Meheco Xinxing Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
- 13.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Human Prothrombin Complex Industry Chain Analysis
- 14.2 Human Prothrombin Complex Industry Raw Material and Suppliers Analysis
- 14.2.1 Human Prothrombin Complex Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Human Prothrombin Complex Typical Downstream Customers
- 14.4 Human Prothrombin Complex Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook